- Home
- FBIO vs PCM Comparison
FBIO vs PCM Comparison
Compare FBIO & PCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FBIO | PCM |
|---|---|---|
| Founded | 2006 | 1993 |
| Country | United States | United States |
| Employees | 78 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.0M | 82.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FBIO | PCM |
|---|---|---|
| Price | $2.67 | $5.69 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | ★ 414.5K | 43.6K |
| Earning Date | 05-15-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.68% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $55.22 | N/A |
| Revenue Next Year | $40.55 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.75 | $5.52 |
| 52 Week High | $4.53 | $6.76 |
Technical Indicators
Market Signals| Indicator | FBIO | PCM |
|---|---|---|
| Relative Strength Index (RSI) | 53.50 | 44.37 |
| Support Level | $2.47 | $5.60 |
| Resistance Level | $2.84 | $6.15 |
| Average True Range (ATR) | 0.16 | 0.06 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 56.43 | 46.15 |
Price Performance
Historical ComparisonAbout FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.
About PCM PCM Fund Inc.
Pcm Fund Inc is a closed-end investment management company. Its investment objective is to seek current income as a primary focus and also capital appreciation. The Fund invests in agency-guaranteed mortgage-backed securities, private-label mortgage-backed securities, high-yield corporate debt securities, and commercial mortgage-backed securities.